Confluent reticulated papillomatosis - Konfluan Papilomatoz Retikulehttps://en.wikipedia.org/wiki/Confluent_and_reticulated_papillomatosis
Konfluan Papilomatoz Retikule (Confluent reticulated papillomatosis) se yon dèrmatoz ichthyosiform akeri ki pa komen, men diferan, ki karakterize pa plak ki pèsistan fè nwa, kal, ki gen tandans lokalize sitou sou kòf santral la. Maladi a ka trete pa Minocycline.

Tretman
#Minocycline
☆ Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
  • Ka tipik ― Li parèt tankou yon tach pigman nwa ki pa gen okenn sentòm (demanjezon, doulè) alantou ren an.
  • Fòm grav
  • Tay la se yon kote ki komen.
References Confluent and Reticulated Papillomatosis 29083642 
NIH
Confluent and reticulated papillomatosis (CRP) , yo rele tou sendwòm Gougerot-Carteaud, rezilta nan kwasans selil po nòmal. Li parèt tankou tach nwa san doulè ki ka rantre nan pi gwo plak, anjeneral parèt sou pwatrin anwo a ak kou adolesan ak jèn adilt. Premye chwa tretman an se minocycline.
Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
 Confluent and reticulated papillomatosis: diagnostic and treatment challenges 27601929 
NIH
CRP anjeneral parèt tankou tach nwa ak plak san sentòm sou po a nan kou a, anbaswa, anwo pwatrin, ak anwo do. Pafwa, li ka gaye jiska fwon an ak desann nan zòn pibyen an. Antibyotik tankou minocycline vin tounen yon chwa tretman pi pito.
CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.